Company Luckwel Pharmaceuticals Inc. Other OTC
Equities
LWEL
US54959L1017
Investment Holding Companies
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kingrich Lee
CEO | Chief Executive Officer | 49 | 01/01/13 |
Mark Carrao
DFI | Director of Finance/CFO | - | 31/08/21 |
Chief Tech/Sci/R&D Officer | - | - | |
Priya Jambhekar
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kingrich Lee
CEO | Chief Executive Officer | 49 | 01/01/13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 147,163,500 | 14,931,388 ( 10.15 %) | 0 | 10.15 % |
Company contact information
Luckwel Pharmaceuticals, Inc.
125 Cambridge Park Drive Suite 301
02140, Cambridge
+617 430 5222
http://www.luckwel.com1st Jan change | Capi. | |
---|---|---|
+190.94% | 6.96B | |
+2.14% | 982M | |
+41.91% | 872M | |
+26.98% | 830M | |
+1.72% | 664M | |
+5.92% | 642M | |
-.--% | 600M | |
+3.61% | 503M | |
-.--% | 500M |